Catton C, Davis A, Bell R, O'Sullivan B, Fornasier V, Wunder J, McLean M
University Musculoskeletal Oncology Unit, Princess Margaret Hospital, Toronto, Canada.
Radiother Oncol. 1996 Dec;41(3):209-14. doi: 10.1016/s0167-8140(96)01856-7.
To assess the results of salvage therapy using surgery alone or surgery and re-irradiation for patients with locally recurrent extremity soft tissue sarcoma (STS) following conservative surgery and radiotherapy.
25 patients with locally recurrent STS after conservative surgery and irradiation were assessed between 1990 and 1995. Two patients with concurrent systemic relapse were treated palliatively. Seven patients were not candidates for conservative re-excision and underwent amputation, 11 patients underwent conservative resection without irradiation. Seven of these patients relapsed, and five went on to receive combined conservative surgery and re-irradiation. A further five patients initially received combined retreatment, for a total of ten patients treated with combined conservative surgery and re-irradiation. Six of these ten patients were treated with brachytherapy alone, one with brachytherapy and external beam therapy, and three with external beam therapy alone. The median retreatment dose was 49.5 Gy (range 35-65 Gy), and the median cumulative soft tissue dose was 100 Gy (range 93-120 Gy).
The median follow-up from the most recent treatment is 24 months (range 7-42 months). At the last follow-up 14 patients are alive and disease free; two are alive with local disease and four with systemic disease, and five are dead of disease. Overall local control is 19/23 (91%). The local control for patients treated with conservative excision without irradiation is 4/11 (36%) and for conservative excision with re-irradiation 10/10 (100%). Six (60%) of these patients experienced significant post-irradiation would-healing complications, but three have recovered fully. Functional scores for the entire treated group are significantly lower after treatment, as are those for patients undergoing combined surgery and re-irradiation, but 70% of those treated with conservative surgery and re-irradiation and a good or excellent post-treatment functional score.
Combined conservative surgery and re-irradiation provided superior local control to local re-excision alone and a functional outcome superior to amputation. Combined treatment with re-irradiation should be considered the primary salvage therapy for patients who fail combined therapy and who are suitable for conservative re-excision. Systemic relapse is a significant problem, and optimal therapy should minimize the risk of local relapse after the initial therapy. Eighteen patients (72%) had a history of intralesional excision as their initial intervention, and suggests that inappropriate initial management is a risk factor for relapse after combined conservative therapy. Improvements in therapy must include the appropriate education of the primary care physicians.
评估对于接受过保守手术和放疗后出现局部复发的肢体软组织肉瘤(STS)患者,单纯手术或手术联合再次放疗的挽救性治疗效果。
1990年至1995年间对25例保守手术和放疗后出现局部复发的STS患者进行了评估。2例同时出现全身复发的患者接受了姑息治疗。7例患者不适合进行保守性再次切除,接受了截肢手术,11例患者接受了未进行放疗的保守性切除。其中7例患者复发,5例随后接受了保守手术联合再次放疗。另外5例患者最初接受了联合再治疗,共有10例患者接受了保守手术联合再次放疗。这10例患者中,6例仅接受了近距离放疗,1例接受了近距离放疗和外照射放疗,3例仅接受了外照射放疗。再次治疗的中位剂量为49.5 Gy(范围35 - 65 Gy),软组织累积中位剂量为100 Gy(范围93 - 120 Gy)。
自最近一次治疗后的中位随访时间为24个月(范围7 - 42个月)。在最后一次随访时,14例患者存活且无疾病;2例患者存活但有局部疾病,4例有全身疾病,5例死于疾病。总体局部控制率为19/23(91%)。未进行放疗的保守性切除患者的局部控制率为4/11(36%),而进行了再次放疗的保守性切除患者的局部控制率为10/10(100%)。这些患者中有6例(60%)出现了明显的放疗后伤口愈合并发症,但3例已完全康复。整个治疗组治疗后的功能评分显著低于治疗前,接受手术联合再次放疗的患者也是如此,但接受保守手术联合再次放疗的患者中有70%的患者治疗后的功能评分良好或优秀。
保守手术联合再次放疗比单纯局部再次切除提供了更好的局部控制,且功能结果优于截肢。对于联合治疗失败且适合保守性再次切除的患者,联合再次放疗应被视为主要的挽救性治疗方法。全身复发是一个重要问题,最佳治疗应将初始治疗后局部复发的风险降至最低。18例患者(72%)最初的干预措施为病损内切除,这表明不适当的初始治疗是联合保守治疗后复发的一个危险因素。治疗的改进必须包括对初级保健医生进行适当的教育。